Amgen Inc.AMGNNASDAQ
Loading
A large-scale business, with exceptional profitability valued in line with the market.
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas.
Comprehensive financial statement data for deep analysis
| Metric | Dec 21 | Dec 22 | Dec 23 | Dec 24 | Dec 25 |
|---|---|---|---|---|---|
| Return on Equity | - | - | - | - | - |
| Return on Invested Capital | - | - | - | - | - |
| Gross Margin | 75.2% | 75.7%↑0.7% | 70.1%↓7.3% | 61.5%↓12.3% | 70.8%↑15.1% |
| Operating Margin | 29.4% | 36.3%↑23.6% | 28.0%↓22.9% | 21.7%↓22.5% | 29.1%↑33.8% |
| Net Margin | 22.7% | 24.9%↑9.7% | 23.8%↓4.3% | 12.2%↓48.6% | 21.0%↑71.5% |
| Earnings Yield | - | - | - | - | - |